Search Results - "AGELAKI, Sofia"

Third Harmonic Generation microscopy distinguishes malignant cell grade in human breast tissue biopsies by Gavgiotaki, Evangelia, Filippidis, George, Tsafas, Vassilis, Bovasianos, Savvas, Kenanakis, George, Georgoulias, Vasilios, Tzardi, Maria, Agelaki, Sofia, Athanassakis, Irene

“…The ability to distinguish and grade malignant cells during surgical procedures in a fast, non-invasive and staining-free manner is of high importance in tumor…”
Get full text

Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer by Papadaki, Chara, Stratigos, Michalis, Markakis, Georgios, Spiliotaki, Maria, Mastrostamatis, Georgios, Nikolaou, Christoforos, Mavroudis, Dimitrios, Agelaki, Sofia

“…In primary breast cancer metastases frequently arise from a state of dormancy that may persist for extended periods of time. We investigated the efficacy of…”
Get full text

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data by Bidard, François-Clément, MD, Peeters, Dieter J, MD, Fehm, Tanja, Prof, Nolé, Franco, MD, Gisbert-Criado, Rafael, MD, Mavroudis, Dimitrios, Prof, Grisanti, Salvatore, MD, Generali, Daniele, MD, Garcia-Saenz, Jose A, MD, Stebbing, Justin, Prof, Caldas, Carlos, Prof, Gazzaniga, Paola, MD, Manso, Luis, MD, Zamarchi, Rita, MD, de Lascoiti, Angela Fernandez, MD, De Mattos-Arruda, Leticia, MD, Ignatiadis, Michail, MD, Lebofsky, Ronald, PhD, van Laere, Steven J, Prof, Meier-Stiegen, Franziska, PhD, Sandri, Maria-Teresa, MD, Vidal-Martinez, Jose, MD, Politaki, Eleni, MSc, Consoli, Francesca, MD, Bottini, Alberto, MD, Diaz-Rubio, Eduardo, Prof, Krell, Jonathan, MD, Dawson, Sarah-Jane, MD, Raimondi, Cristina, MD, Rutten, Annemie, MD, Janni, Wolfgang, Prof, Munzone, Elisabetta, MD, Carañana, Vicente, MD, Agelaki, Sofia, MD, Almici, Camillo, MD, Dirix, Luc, MD, Solomayer, Erich-Franz, Prof, Zorzino, Laura, MSc, Johannes, Helene, MSc, Reis-Filho, Jorge S, Prof, Pantel, Klaus, Prof, Pierga, Jean-Yves, Prof, Michiels, Stefan, PhD

“…Summary Background We aimed to assess the clinical validity of circulating tumour cell (CTC) quantification for prognostication of patients with metastatic…”
Get full text

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer by Liouta, Galateia, Adamaki, Maria, Tsintarakis, Antonis, Zoumpourlis, Panagiotis, Liouta, Anastasia, Agelaki, Sofia, Zoumpourlis, Vassilis

“…Head and neck squamous cell carcinoma (HNSCC) is a term collectively used to describe all cancers that develop in the oral and nasal cavities, the paranasal…”
Get full text

Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study by Rounis, Konstantinos, Makrakis, Dimitrios, Papadaki, Chara, Monastirioti, Alexia, Vamvakas, Lambros, Kalbakis, Konstantinos, Gourlia, Krystallia, Xanthopoulos, Iordanis, Tsamardinos, Ioannis, Mavroudis, Dimitrios, Agelaki, Sofia

“…Objective We prospectively recorded clinical and laboratory parameters from patients with metastatic non-small cell lung cancer (NSCLC) treated with 2nd line…”
Get full text

May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment? by Psilopatis, Iason, Karniadakis, Ioannis, Danos, Konstantinos Stylianos, Vrettou, Kleio, Michaelidou, Kleita, Mavridis, Konstantinos, Agelaki, Sofia, Theocharis, Stamatios

“…Lung cancer (LC) is the leading cause of cancer death in the United States. Erythropoietin-producing hepatocellular receptors (EPHs) comprise the largest…”
Get full text

Circulating Biomarkers in Non–Small-Cell Lung Cancer: Current Status and Future Challenges by Matikas, Alexios, Syrigos, Konstantinos N, Agelaki, Sofia

“…Abstract Despite recent advances, non–small-cell lung cancer remains a devastating disease and carries a grim prognosis. Major contributing factors include…”
Get full text

Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study by Rounis, Konstantinos, Makrakis, Dimitrios, Papadaki, Chara, Monastirioti, Alexia, Vamvakas, Lambros, Kalbakis, Konstantinos, Gourlia, Krystallia, Xanthopoulos, Iordanis, Tsamardinos, Ioannis, Mavroudis, Dimitrios, Agelaki, Sofia

“…[This corrects the article DOI: 10.1371/journal.pone.0252537.]…”
Get full text

Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors by Makrakis, Dimitrios, Rounis, Konstantinos, Tsigkas, Alexandros-Pantelis, Georgiou, Alexandra, Galanakis, Nikolaos, Tsakonas, George, Ekman, Simon, Papadaki, Chara, Monastirioti, Alexia, Kontogianni, Meropi, Gioulbasanis, Ioannis, Mavroudis, i, Agelaki, Sofia

“…[This corrects the article DOI: 10.1371/journal.pone.0277708.]…”
Get full text

Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer by Papadaki, Chara, Stratigos, Michalis, Markakis, Georgios, Spiliotaki, Maria, Mastrostamatis, Georgios, Nikolaou, Christoforos, Mavroudis, Dimitrios, Agelaki, Sofia

Get full text

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer by XENIDIS, Nikolaos, IGNATIADIS, Michail, GEORGOULIAS, Vassilis, MAVROUDIS, Dimitris, APOSTOLAKI, Stella, PERRAKI, Maria, KALBAKIS, Kostas, AGELAKI, Sofia, STATHOPOULOS, Efstathios N, CHLOUVERAKIS, Grigorios, LIANIDOU, Evi, KAKOLYRIS, Stylianos

“…To evaluate the prognostic significance of cytokeratin-19 (CK-19) mRNA-positive circulating tumor cells (CTCs) in peripheral blood of women with early-stage…”
Get full text

The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach by Tsiligianni, Ioanna, Christodoulakis, Antonios, Monastirioti, Alexia, Mavroudis, Dimitrios, Agelaki, Sofia

“…The early diagnosis of lung cancer improves the probability of successful treatment. However, patients and physicians face several difficulties that can…”
Get full text

Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) by Papadaki, Maria A, Messaritakis, Ippokratis, Fiste, Oraianthi, Souglakos, John, Politaki, Eleni, Kotsakis, Athanasios, Georgoulias, Vassilis, Mavroudis, Dimitrios, Agelaki, Sofia

“…We herein investigated the detection frequency and clinical relevance of circulating tumor cells (CTCs) in chemotherapy-naïve stage IIIB/IV non-small cell lung…”
Get full text

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer by Agelaki, Sofia, Kalykaki, Antonia, Markomanolaki, Harris, Papadaki, Maria A, Kallergi, Galatea, Hatzidaki, Dora, Kalbakis, Kostas, Mavroudis, Dimitrios, Georgoulias, Vassilis

“…To evaluate the efficacy of lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, in therapy-resistant HER2-positive CTCs in metastatic breast cancer…”
Get full text

Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors by Makrakis, Dimitrios, Rounis, Konstantinos, Tsigkas, Alexandros-Pantelis, Georgiou, Alexandra, Galanakis, Nikolaos, Tsakonas, George, Ekman, Simon, Papadaki, Chara, Monastirioti, Alexia, Kontogianni, Meropi, Gioulbasanis, Ioannis, Mavroudis, Dimitris, Agelaki, Sofia

“…Obesity and sarcopenia have been reported to affect outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors…”
Get full text

Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape? by Kyriazi, Athina A, Karaglani, Makrina, Agelaki, Sofia, Baritaki, Stavroula

“…The role of the microbiome in cancer and its crosstalk with the tumor microenvironment (TME) has been extensively studied and characterized. An emerging field…”
Get full text

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients by Kallergi, Galatea, Agelaki, Sofia, Kalykaki, Antonia, Stournaras, Christos, Mavroudis, Dimitris, Georgoulias, Vassilis

“…The phosphoinositide-3 kinase (PI3K)/Akt pathway, operating downstream of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor…”
Get full text

A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study by Agelaki, Sofia, Boukovinas, Ioannis, Athanasiadis, Ilias, Trimis, Georgios, Dimitriadis, Ioannis, Poughias, Lazaros, Morais, Edith, Sabale, Ugne, Bencina, Goran, Athanasopoulos, Charalampos

“…Aims The aim of this systematic literature review was to provide updated information on human papillomavirus (HPV) prevalence in locally and regionally…”
Get full text

Clinical Controversy Surrounding the Differential Diagnosis of Branchiogenic Carcinoma by Karatzanis, Alexander, Mylopotamitaki, Kleanthi, Lagoudaki, Eleni, Prokopakis, Emmanuel, Agelaki, Sofia

“…Clinical evaluation, differential diagnosis, and management of a neck mass constitute commonly encountered problems for the head and neck surgeon. An…”
Get full text

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer by Politaki, Eleni, Agelaki, Sofia, Apostolaki, Stella, Hatzidaki, Dora, Strati, Areti, Koinis, Filippos, Perraki, Maria, Saloustrou, Georgia, Stoupis, Giannis, Kallergi, Galatea, Spiliotaki, Maria, Skaltsi, Tereza, Lianidou, Evi, Georgoulias, Vassilis, Mavroudis, Dimitrios

“…Background: We directly compared CTC detection rates and prognostic significance, using three different methods in patients with breast cancer (BC). Methods:…”
Get full text